Cargando…
NDC1 is a Prognostic Biomarker and Associated with Immune Infiltrates in Colon Cancer
BACKGROUND: Colon cancer is one of the most lethal cancers in the world. NDC1 is a crucial membrane-integral nucleoporin of nuclear pore complexes. The clinical significance of NDC1 in colon cancer has not been demonstrated to date. Therefore, we determined to evaluate the association between NDC1 a...
Autores principales: | Liu, Meng, Yuan, Rui, Liu, Shifei, Xue, Yonggan, Wang, Xuning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630367/ https://www.ncbi.nlm.nih.gov/pubmed/34858049 http://dx.doi.org/10.2147/IJGM.S325720 |
Ejemplares similares
-
Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer
por: Shen, Qian, et al.
Publicado: (2023) -
Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer
por: Liu, Jing, et al.
Publicado: (2021) -
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers
por: Pan, Jing-hua, et al.
Publicado: (2019) -
Ndc1 catches the shuttle
por: Leslie, Mitch
Publicado: (2014) -
Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colon cancer
por: Xue, Yonggan, et al.
Publicado: (2022)